Literature DB >> 19380474

Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms.

Takeshi Shimizu1, Yuko Ohta, Masatoshi Noda.   

Abstract

Shiga toxin 1 (Stx1) is located in the periplasmic fraction, while Stx2 is found in the extracellular fraction, suggesting that enterohemorrhagic Escherichia coli (EHEC) contains a specific Stx2 release system. Both stx(1) and stx(2) are found within the late operons of Stx-encoding phages. Stx2 production is greatly induced by mitomycin C, suggesting that stx(2) can transcribe from the late phage promoter of the Stx2-encoding phage. However, the Stx1 promoter adjacent to stx(1) is a dominant regulatory element in Stx1 production. With the deletion of phage lysis genes of the Stx2-encoding phage, Stx2 remains in the bacterial cells. Further, we demonstrate that the Stx2-encoding phage, but not the Stx1-encoding phage, is spontaneously induced at extremely low rates. These results indicate that spontaneously specific Stx2-encoding phage induction is involved in specific Stx2 release from bacterial cells. Furthermore, to examine whether another system for specific Stx2 release is present in EHEC, we analyze the stx-replaced mutants. As expected, Stx2 derived from the Stx1 promoter is located in both the extracellular and cell-associated fractions, while mutant Stx2 (B subunit, S31N) derived from the Stx1 promoter is found only in the cell-associated fraction. These results indicate that EHEC has another Stx2 release system that strictly recognizes the serine 31 residue of the B subunit. Overall, we present evidence that specific Stx2 release from bacterial cells is involved in both the Stx2-encoding phage induction system and another Stx2 release system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380474      PMCID: PMC2708558          DOI: 10.1128/IAI.00060-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Bacteriophage control of bacterial virulence.

Authors:  Patrick L Wagner; Matthew K Waldor
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system.

Authors:  Jonathan Livny; David I Friedman
Journal:  Mol Microbiol       Date:  2004-03       Impact factor: 3.501

3.  Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B.

Authors:  S De Grandis; J Ginsberg; M Toone; S Climie; J Friesen; J Brunton
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

4.  Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli.

Authors:  A Huang; J Friesen; J L Brunton
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

Review 5.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

6.  Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

Authors:  S B Calderwood; F Auclair; A Donohue-Rolfe; G T Keusch; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

8.  Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

Authors:  A D O'Brien; J W Newland; S F Miller; R K Holmes; H W Smith; S B Formal
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

9.  Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.

Authors:  Marie E Fraser; Masao Fujinaga; Maia M Cherney; Angela R Melton-Celsa; Edda M Twiddy; Alison D O'Brien; Michael N G James
Journal:  J Biol Chem       Date:  2004-04-09       Impact factor: 5.157

10.  An association of 27- and 40-kDa molecules with glycolipids that bind A-B bacterial enterotoxins to cultured cells.

Authors:  Takeshi Shimizu; Takashi Hamabata; Akemi Yoshiki; Takeya Hori; Satoru Ito; Yoshifumi Takeda; Hideo Hayashi
Journal:  Biochim Biophys Acta       Date:  2003-06-10
View more
  29 in total

1.  Induction of Shiga Toxin-Encoding Prophage by Abiotic Environmental Stress in Food.

Authors:  Yuan Fang; Ryan G Mercer; Lynn M McMullen; Michael G Gänzle
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

Review 2.  Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions.

Authors:  Arun M Nanda; Kai Thormann; Julia Frunzke
Journal:  J Bacteriol       Date:  2014-11-17       Impact factor: 3.490

Review 3.  After the Fact(or): Posttranscriptional Gene Regulation in Enterohemorrhagic Escherichia coli O157:H7.

Authors:  Amber B Sauder; Melissa M Kendall
Journal:  J Bacteriol       Date:  2018-09-10       Impact factor: 3.490

4.  Spread of a distinct Stx2-encoding phage prototype among Escherichia coli O104:H4 strains from outbreaks in Germany, Norway, and Georgia.

Authors:  Lothar Beutin; Jens Andre Hammerl; Eckhard Strauch; Jochen Reetz; Ralf Dieckmann; Ylanna Kelner-Burgos; Annett Martin; Angelika Miko; Nancy A Strockbine; Björn Arne Lindstedt; Detlef Horn; Hella Monse; Bruno Huettel; Ines Müller; Kurt Stüber; Richard Reinhardt
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coli.

Authors:  Craig Skinner; Guodong Zhang; Stephanie Patfield; Xiaohua He
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

6.  Vitamin K Analogs Influence the Growth and Virulence Potential of Enterohemorrhagic Escherichia coli.

Authors:  Anne Kijewski; Ingun Lund Witsø; Hildegunn Iversen; Helene Thorsen Rønning; Trine L'Abée-Lund; Yngvild Wasteson; Toril Lindbäck; Marina Aspholm
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

Review 7.  Altruism of Shiga toxin-producing Escherichia coli: recent hypothesis versus experimental results.

Authors:  Joanna M Loś; Marcin Loś; Alicja Węgrzyn; Grzegorz Węgrzyn
Journal:  Front Cell Infect Microbiol       Date:  2013-01-04       Impact factor: 5.293

Review 8.  Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.

Authors:  Elias A Rahal; Natalie Kazzi; Farah J Nassar; Ghassan M Matar
Journal:  Front Cell Infect Microbiol       Date:  2012-11-15       Impact factor: 5.293

9.  Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB/c mice.

Authors:  Elias A Rahal; Natalie Kazzi; Ahmad Sabra; Alexander M Abdelnoor; Ghassan M Matar
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-09-12       Impact factor: 3.944

10.  Purification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2.

Authors:  Craig Skinner; Stephanie McMahon; Reuven Rasooly; John Mark Carter; Xiaohua He
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.